Masatoshi Ishigami

7.3k total citations · 1 hit paper
278 papers, 4.7k citations indexed

About

Masatoshi Ishigami is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Masatoshi Ishigami has authored 278 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Epidemiology, 136 papers in Hepatology and 90 papers in Surgery. Recurrent topics in Masatoshi Ishigami's work include Liver Disease Diagnosis and Treatment (109 papers), Hepatitis C virus research (70 papers) and Pancreatic and Hepatic Oncology Research (52 papers). Masatoshi Ishigami is often cited by papers focused on Liver Disease Diagnosis and Treatment (109 papers), Hepatitis C virus research (70 papers) and Pancreatic and Hepatic Oncology Research (52 papers). Masatoshi Ishigami collaborates with scholars based in Japan, United States and South Korea. Masatoshi Ishigami's co-authors include Hidemi Goto, Yoshiki Hirooka, Takashi Honda, Yoshiaki Katano, Kazuhiko Hayashi, Yoji Ishizu, Teiji Kuzuya, Eizaburo Ohno, Hiroki Kawashima and Akihiro Ito and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Masatoshi Ishigami

268 papers receiving 4.7k citations

Hit Papers

Association Between Fibrosis Stage and Outcomes of Patien... 2020 2026 2022 2024 2020 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
    2020 681 citations Masatoshi Ishigami, Hidenori Toyoda et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masatoshi Ishigami Japan 33 2.5k 1.9k 1.4k 1.2k 565 278 4.7k
Rosa Miquel Spain 44 3.2k 1.3× 3.0k 1.6× 2.0k 1.4× 926 0.8× 992 1.8× 156 6.9k
Dominique Wendum France 49 3.7k 1.5× 3.9k 2.1× 2.4k 1.6× 1.1k 0.9× 1.4k 2.5× 149 7.5k
Francesco Tovoli Italy 29 1.5k 0.6× 1.3k 0.7× 857 0.6× 589 0.5× 384 0.7× 132 3.3k
Lünan Yan China 31 2.3k 0.9× 3.2k 1.7× 2.2k 1.6× 781 0.6× 330 0.6× 275 5.1k
Masashi Hirooka Japan 33 2.2k 0.9× 2.1k 1.1× 662 0.5× 404 0.3× 301 0.5× 196 3.6k
Kwan Sik Lee South Korea 35 2.6k 1.0× 2.9k 1.5× 831 0.6× 550 0.5× 477 0.8× 150 4.6k
Sara Massironi Italy 35 2.4k 1.0× 957 0.5× 1.2k 0.9× 1.3k 1.1× 313 0.6× 150 4.1k
Roger L. Jenkins United States 40 1.8k 0.7× 2.5k 1.3× 2.4k 1.7× 648 0.5× 343 0.6× 131 4.7k
Kyuichi Tanikawa Japan 39 2.2k 0.9× 2.5k 1.3× 1.3k 0.9× 573 0.5× 763 1.4× 201 4.8k
Hitoshi Takagi Japan 32 1.3k 0.5× 1.5k 0.8× 963 0.7× 657 0.5× 649 1.1× 212 3.5k

Countries citing papers authored by Masatoshi Ishigami

Since Specialization
Citations

This map shows the geographic impact of Masatoshi Ishigami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Ishigami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Ishigami more than expected).

Fields of papers citing papers by Masatoshi Ishigami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Ishigami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Ishigami. The network helps show where Masatoshi Ishigami may publish in the future.

Co-authorship network of co-authors of Masatoshi Ishigami

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Ishigami. A scholar is included among the top collaborators of Masatoshi Ishigami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Ishigami. Masatoshi Ishigami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Kenta, Takashi Honda, Shinya Yokoyama, et al.. (2024). Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma. Cancers. 16(9). 1675–1675. 2 indexed citations
2.
Imai, Norihiro, Yuki Ohsaki, Jinglei Cheng, et al.. (2023). Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases. Scientific Reports. 13(1). 6851–6851. 8 indexed citations
3.
4.
Nakamura, Masanao, Takashi Honda, Takeshi Yamamura, et al.. (2023). Efficacy of 1‐kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double‐blind, placebo‐controlled pilot study. Alimentary Pharmacology & Therapeutics. 57(11). 1249–1257. 22 indexed citations
5.
Yamamoto, Takafumi, Takanori Ito, Masatoshi Ishigami, et al.. (2022). Clustering using unsupervised machine learning to stratify the risk of immune‐related liver injury. Journal of Gastroenterology and Hepatology. 38(2). 251–258. 8 indexed citations
6.
Sawada, Tsunaki, Takeshi Yamamura, Keiko Maeda, et al.. (2022). Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan. BMC Gastroenterology. 22(1). 342–342. 19 indexed citations
7.
Ishizu, Yoji, Yukio Ando, Shinya Yokoyama, et al.. (2022). An improved method to assess skeletal muscle mass in patients with liver cirrhosis based on computed tomography images. Hepatology Research. 52(11). 937–946. 5 indexed citations
8.
Mori, Hiroshi, Hiroki Kawashima, Eizaburo Ohno, et al.. (2022). Comparison of an Inside Stent and a Fully Covered Self-Expandable Metallic Stent as Preoperative Biliary Drainage for Patients with Resectable Perihilar Cholangiocarcinoma. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–9. 5 indexed citations
9.
Yamamoto, Kenta, Takashi Honda, Takanori Ito, et al.. (2022). Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma. Digestive Diseases. 41(1). 138–147. 7 indexed citations
10.
Kawashima, Hiroki, Eizaburo Ohno, Takuya Ishikawa, et al.. (2021). Measurement of fasting breath hydrogen concentration as a simple diagnostic method for pancreatic exocrine insufficiency. BMC Gastroenterology. 21(1). 211–211. 4 indexed citations
11.
Ishigami, Masatoshi, Takashi Honda, Teiji Kuzuya, et al.. (2020). Revisiting the indications for liver transplantation in cirrhotic patients considering the long‐term outcomes of cirrhotic patients. Journal of Hepato-Biliary-Pancreatic Sciences. 27(9). 655–662. 5 indexed citations
12.
Nakamura, Masanao, Takeshi Yamamura, Keiko Maeda, et al.. (2020). The microbiome can predict mucosal healing in small intestine in patients with Crohn’s disease. Journal of Gastroenterology. 55(12). 1138–1149. 17 indexed citations
13.
Nakamura, Masanao, Takeshi Yamamura, Keiko Maeda, et al.. (2020). Lewis score on capsule endoscopy can predict the prognosis in patients with small bowel lesions of Crohn's disease. Journal of Gastroenterology and Hepatology. 36(7). 1851–1858. 12 indexed citations
14.
Kuzuya, Teiji, Masatoshi Ishigami, Takanori Ito, et al.. (2019). Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma. Hepatology Research. 50(3). 374–381. 25 indexed citations
15.
16.
Ishigami, Masatoshi, Yoshihiro Matsushita, Takanori Ito, et al.. (2016). Multifaceted Therapeutic Benefits of Factors Derived From Dental Pulp Stem Cells for Mouse Liver Fibrosis. Stem Cells Translational Medicine. 5(10). 1416–1424. 53 indexed citations
17.
Kuzuya, Teiji, Masatoshi Ishigami, Yoji Ishizu, et al.. (2016). Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma. Oncology. 91(5). 261–266. 9 indexed citations
18.
Ishigami, Masatoshi, Kazuhiko Hayashi, Shinya Wakusawa, et al.. (2015). Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes. Journal of Clinical and Translational Hepatology. 3(2). 85–92. 8 indexed citations
19.
Honda, Takashi, Masatoshi Ishigami, Hiroko Masuda, et al.. (2014). Effect of peginterferon alfa‐2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology. 30(2). 321–328. 7 indexed citations
20.
Hayashi, Kazuhiko, Yoshiaki Katano, Yoji Ishizu, et al.. (2014). Association of interleukin 28 B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness. Journal of Gastroenterology and Hepatology. 30(1). 178–183. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Miquel Breakdown of academic impact, for papers by Dominique Wendum Breakdown of academic impact, for papers by Francesco Tovoli Breakdown of academic impact, for papers by Lünan Yan Breakdown of academic impact, for papers by Masashi Hirooka Breakdown of academic impact, for papers by Kwan Sik Lee Breakdown of academic impact, for papers by Sara Massironi Breakdown of academic impact, for papers by Roger L. Jenkins Breakdown of academic impact, for papers by Kyuichi Tanikawa Breakdown of academic impact, for papers by Hitoshi Takagi
Rankless by CCL
2026